No Data
No Data
No Data
No Data
No Data
Mineralys Therapeutics Board Member Announces Departure
TipRanksApr 4 08:12 ET
Goldman Starts Mineralys at Buy, Cites Upcoming Drug Data
Seeking AlphaApr 2 14:37 ET
QuidelOrtho Stock Falls 11% on Savanna PVP4+ Assay Update
Seeking AlphaApr 2 14:01 ET
Express News | Mineralys Therapeutics Shares Are Trading Higher After Goldman Sachs Initiated Coverage on the Stock With a Buy Rating and Announced a Price Target of $30
Moomoo 24/7Apr 2 08:46 ET
Express News | Goldman Sachs Initiates Coverage On Mineralys Therapeutics With Buy Rating, Announces Price Target of $30
Moomoo 24/7Apr 2 07:10 ET
Mineralys Therapeutics Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/02/2024 126.93% Goldman Sachs → $30 Initiates Coverage On → Buy 08/08/2023 179.88% Credit Suisse $38 →
BenzingaApr 2 07:10 ET
No Data
No Data